![Aadel Al-Jadda](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Aadel Al-Jadda is the founder who currently holds the position of Vice President of Research & Development at Akura Medical, Inc. The company was founded in 2019.
Actieve functies van Aadel Al-Jadda
Bedrijven | Functie | Begin |
---|---|---|
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Oprichter | 01-01-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Health Technology |